CBGL (Cannabis Global) Current Ratio: 0.21 (As of May. 2022)


What is Cannabis Global Current Ratio?

Cannabis Global CBGL Current Ratio is 0.21 as of May. 2022.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cannabis Global's current ratio for the quarter that ended in May. 2022 was 0.21.

Cannabis Global has a current ratio of 0.21. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Cannabis Global has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Cannabis Global's Current Ratio or its related term are showing as below:

CBGL's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.995
* Ranked among companies with meaningful Current Ratio only.

Cannabis Global  (OTCPK:CBGL) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Cannabis Global Current Ratio Related Terms


Cannabis Global Current Ratio Historical Data

* Premium members only.

The historical data trend for Cannabis Global's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global Current Ratio Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.04 1.01 0.02 0.05

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.05 0.12 0.22 0.21

CBGL vs MILC, BBBT, GCAN: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Global Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's Current Ratio distribution charts can be found below:

* The bar in red indicates where Cannabis Global's Current Ratio falls into.



Cannabis Global Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Cannabis Global's Current Ratio for the fiscal year that ended in Aug. 2021 is calculated as

Current Ratio (A: Aug. 2021 )=Total Current Assets (A: Aug. 2021 )/Total Current Liabilities (A: Aug. 2021 )
=0.442/8.747
=0.05

Cannabis Global's Current Ratio for the quarter that ended in May. 2022 is calculated as

Current Ratio (Q: May. 2022 )=Total Current Assets (Q: May. 2022 )/Total Current Liabilities (Q: May. 2022 )
=1.297/6.114
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.21 mean?
Cannabis Global (CBGL) has a Current Ratio of 0.21 as of May. 2022.
Is Cannabis Global's Current Ratio too high?
Cannabis Global's current Current Ratio is 0.21. The Drug Manufacturers industry median Current Ratio is 2.00. Cannabis Global's value of 0.21 is 89.5% below this industry median.
How does Cannabis Global's Current Ratio compare to MILC and BBBT?
Cannabis Global's Current Ratio of 0.21 can be compared against companies in the Drug Manufacturers industry. The industry median Current Ratio is 2.00. Cannabis Global's value of 0.21 is 89.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Global's current Current Ratio of 0.21 is 89.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Global's current Current Ratio is 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current Current Ratio of 0.21. The current Current Ratio is 0.21 and 89.5% below the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Cannabis Global (CBGL), the current Current Ratio is 0.21 as of May. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Global Business Description

Address 520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.